1 Min Read
Feb 5 (Reuters) - NOVO NORDISK:
* BOTH DIABETES MEDICATIONS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION IN 2017 Further company coverage: (Copenhagen newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.